Mark Polhemus

Author PubWeight™ 10.34^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya.	PLoS One	2009	2.79
2	DNA prime/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity.	PLoS One	2013	1.47
3	Immunization with pre-erythrocytic antigen CelTOS from Plasmodium falciparum elicits cross-species protection against heterologous challenge with Plasmodium berghei.	PLoS One	2010	1.24
4	Old world leishmaniasis: an emerging infection among deployed US military and civilian workers.	Clin Infect Dis	2004	1.24
5	First-in-human evaluation of genetically attenuated Plasmodium falciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteers.	Vaccine	2013	1.16
6	Results from tandem Phase 1 studies evaluating the safety, reactogenicity and immunogenicity of the vaccine candidate antigen Plasmodium falciparum FVO merozoite surface protein-1 (MSP1(42)) administered intramuscularly with adjuvant system AS01.	Malar J	2013	0.97
7	Cardiac infection and sepsis in 3 intravenous bath salts drug users.	Clin Infect Dis	2013	0.78
8	Pharmacokinetic evaluation of intravenous artesunate in adults with uncomplicated falciparum malaria in Kenya: a phase II study.	Malar J	2014	0.75